I think PBMs--this is a really interesting hearing, okay? But if you eliminate all the profitability and all the incentives for creating new drugs, you have not really made a dent in our health-care spend.
Ron Johnson emphasizes the importance of profitability in drug development amidst healthcare spending discussions.
Share
More from Ron Johnson
Obviously, with the president at his direction, this is what he wants to do.
So the proper percentage is 104 divided by 127, an 82% miscarriage rate with women who got the injection in the first second trimester.
Currently, VAERS shows 1,676,100 cumulative worldwide adverse events and 39,099 deaths associated with the COVID-19 injection, with 9,332 (24%) of the deaths occurring within 2 days of injection.
Other voices in this conversation
